Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CAH
stocks logo

CAH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q3
FY2026Q4
64.88B
+17.4%
2.295
+18.93%
62.77B
+14.38%
2.689
+14.42%
66.78B
+11%
2.289
+10.03%
Estimates Revision
The market is revising Upward the revenue expectations for Cardinal Health, Inc. (CAH) for FY2026, with the revenue forecasts being adjusted by 3.92% over the past three months. During the same period, the stock price has changed by 33.18%.
Revenue Estimates for FY2026
Revise Upward
up Image
+3.92%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
up Image
+4.17%
In Past 3 Month
Stock Price
Go Up
up Image
+33.18%
In Past 3 Month
Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 211.83 USD with a low forecast of 187.00 USD and a high forecast of 232.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 211.83 USD with a low forecast of 187.00 USD and a high forecast of 232.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
2 Hold
0 Sell
Strong Buy
Current: 199.190
sliders
Low
187.00
Averages
211.83
High
232.00
Current: 199.190
sliders
Low
187.00
Averages
211.83
High
232.00
Morgan Stanley
NULL -> Overweight
maintain
$190 -> $224
2025-11-07
Reason
Morgan Stanley
Price Target
$190 -> $224
2025-11-07
maintain
NULL -> Overweight
Reason
Morgan Stanley raised the firm's price target on Cardinal Health to $224 from $190 and keeps an Overweight rating on the shares.
TD Cowen
Charles Rhyee
maintain
$183 -> $225
2025-11-03
Reason
TD Cowen
Charles Rhyee
Price Target
$183 -> $225
2025-11-03
maintain
Reason
TD Cowen analyst Charles Rhyee raised the firm's price target on Cardinal Health to $225 from $183 and keeps a Buy rating on the shares. The firm update their estimates following a F1Q26 where the company raised its adj. EPS guide, Pharma guide, and Other AOI guide.
Jefferies
Buy
maintain
$190 -> $220
2025-11-03
Reason
Jefferies
Price Target
$190 -> $220
2025-11-03
maintain
Buy
Reason
Jefferies raised the firm's price target on Cardinal Health to $220 from $190 and keeps a Buy rating on the shares. The firm notes the company delivered a strong Q3, raising guidance and, most importantly, delivering strong core Pharma numbers against a low buy-side bar. Despite the raise, FY26 guidance still looks conservative to Jefferies, given the strong Q1 performance even after accounting for modest accretion from the now closed Solaris acquisition. The firm remains bullish, as Cardinal Health continues to execute on its strategic priorities with line of sight to achieve its +12%-14% EPS LRP.
Mizuho
Steven Valiquette
Outperform
maintain
$170 -> $210
2025-11-03
Reason
Mizuho
Steven Valiquette
Price Target
$170 -> $210
2025-11-03
maintain
Outperform
Reason
Mizuho analyst Steven Valiquette raised the firm's price target on Cardinal Health to $210 from $170 and keeps an Outperform rating on the shares. With greater momentum following the company's fiscal Q1 report and the Solaris deal, the firm raised its FY26 EPS estimate to $9.80 from $9.40 and its FY27 estimate to $11.20 from $10.60, the analyst tells investors.
UBS
Buy
maintain
$185 -> $220
2025-10-31
Reason
UBS
Price Target
$185 -> $220
2025-10-31
maintain
Buy
Reason
UBS raised the firm's price target on Cardinal Health to $220 from $185 and keeps a Buy rating on the shares. The firm updated its model following the Q1 results.
Evercore ISI
Elizabeth Anderson
Outperform
maintain
$190 -> $220
2025-10-31
Reason
Evercore ISI
Elizabeth Anderson
Price Target
$190 -> $220
2025-10-31
maintain
Outperform
Reason
Evercore ISI analyst Elizabeth Anderson raised the firm's price target on Cardinal Health to $220 from $190 and keeps an Outperform rating on the shares. Cardinal Health kicked off FY26 with a "bang," showcasing robust performance across all segments and a notable 37% year-over-year adjusted operating income increase as Pharma execution shines, "Other" accelerates, and Global Medical Products and Distribution margins recover, the analyst tells investors in a research note. The firm added that the outlook suggests even more potential upside.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Cardinal Health Inc (CAH.N) is 19.98, compared to its 5-year average forward P/E of 12.83. For a more detailed relative valuation and DCF analysis to assess Cardinal Health Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Overvalued
5Y Average PE
12.83
Current PE
19.98
Overvalued PE
15.47
Undervalued PE
10.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
8.67
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
10.24
Undervalued EV/EBITDA
7.11

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.11
Current PS
0.00
Overvalued PS
0.13
Undervalued PS
0.08
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 9666.43% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 9666.43% over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

CAH News & Events

Events Timeline

(ET)
2025-10-30
09:55:03
Significant Early Gainers in Liquid Options on October 30th
select
2025-10-30
07:09:26
Cardinal Health increases FY26 EPS forecast to $9.65-$9.85, up from $9.30-$9.50
select
2025-10-30
07:08:03
Cardinal Health Announces Q1 Earnings Per Share of $2.55, Exceeding Consensus Estimate of $2.17
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.0
12-02NASDAQ.COM
Baxter Announces Recall for Permanent Withdrawal of Life2000 Ventilator

  • Recall of Life2000 Ventilation System: Baxter has recalled its Life2000 Ventilation System due to a serious cybersecurity issue that could lead to unauthorized access and potential failure of life-support functions, with the FDA categorizing this recall as the most serious type.

  • Market Impact and Stock Performance: Despite the recall, Baxter's stock price has increased by 0.9% since the FDA notice, although the company's stock has declined 34.6% this year compared to the industry’s 4.9% gain.

  • Previous Recalls and Safety Concerns: This recall follows two earlier recalls in 2023 and 2024 related to battery-charging issues and oxygen-desaturation risks, with no reported serious injuries or deaths linked to the current cybersecurity issue as of April 2025.

  • Recommendations for Users: Baxter has advised users to stop using the Life2000 ventilators and consult healthcare providers for alternative medical equipment, while healthcare facilities are instructed to discontinue the use of all Life2000 devices.

[object Object]
Preview
3.0
11-30NASDAQ.COM
Quantitative Stock Analysis for CAH

  • Cardinal Health Inc. Overview: Cardinal Health Inc. (CAH) is rated highly by Validea's Multi-Factor Investor model, achieving a score of 100% based on its fundamentals and valuation, indicating strong interest from the strategy.

  • Investment Strategy: The Multi-Factor Investor model, developed by Pim van Vliet, focuses on low volatility stocks with strong momentum and high net payout yields, which have historically outperformed high volatility stocks with less risk.

  • Pim van Vliet's Background: Pim van Vliet, head of Conservative Equities at Robeco Asset Management, has researched conservative factor investing and authored the book "High Returns From Low Risk," emphasizing the paradox of achieving high returns with low risk.

  • Validea's Research Service: Validea provides investment research based on the strategies of renowned investors, offering stock analysis and model portfolios aimed at long-term market outperformance.

[object Object]
Preview
2.0
11-28NASDAQ.COM
Cardinal Health (CAH) Sees 2.00% Increase Over the Past Week: Key Insights

  • Momentum Investing Overview: Momentum investing involves buying stocks that are trending upwards, with the expectation that they will continue to rise. The Zacks Momentum Style Score helps investors identify stocks with strong momentum indicators.

  • Cardinal Health's Performance: Cardinal Health (CAH) has a Momentum Style Score of A and a Zacks Rank of #2 (Buy), with significant price increases over various time frames, outperforming both its industry and the S&P 500.

  • Earnings Estimate Revisions: CAH has seen a positive trend in earnings estimate revisions, with multiple upward adjustments in estimates for both the current and next fiscal year, contributing to its strong momentum score.

  • Investment Opportunities: The article highlights the potential for significant investment gains through advancements in artificial intelligence and quantum computing, encouraging investors to consider stocks positioned to benefit from these technological shifts.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Cardinal Health Inc (CAH) stock price today?

The current price of CAH is 199.19 USD — it has decreased -0.26 % in the last trading day.

arrow icon

What is Cardinal Health Inc (CAH)'s business?

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

arrow icon

What is the price predicton of CAH Stock?

Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 211.83 USD with a low forecast of 187.00 USD and a high forecast of 232.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Cardinal Health Inc (CAH)'s revenue for the last quarter?

Cardinal Health Inc revenue for the last quarter amounts to 64.01B USD, increased 22.44 % YoY.

arrow icon

What is Cardinal Health Inc (CAH)'s earnings per share (EPS) for the last quarter?

Cardinal Health Inc. EPS for the last quarter amounts to 1.88 USD, increased 10.59 % YoY.

arrow icon

What changes have occurred in the market's expectations for Cardinal Health Inc (CAH)'s fundamentals?

The market is revising Upward the revenue expectations for Cardinal Health, Inc. (CAH) for FY2026, with the revenue forecasts being adjusted by 3.92% over the past three months. During the same period, the stock price has changed by 33.18%.
arrow icon

How many employees does Cardinal Health Inc (CAH). have?

Cardinal Health Inc (CAH) has 57700 emplpoyees as of December 05 2025.

arrow icon

What is Cardinal Health Inc (CAH) market cap?

Today CAH has the market capitalization of 47.33B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free